On March 5, 2018 Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) reported that company executives are scheduled to participate in the following upcoming investor conferences (Press release, Ligand, MAR 5, 2018, View Source [SID1234524395]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

• 30th Annual ROTH Conference in Dana Point, California. Presentation takes place on Monday, March 12, 2018 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time). Matt Foehr, COO will attend for Ligand.

• Barclays Global Healthcare Conference in Miami. Presentation takes place on Tuesday, March 13, 2018 at 8:30 a.m. Eastern time (5:30 a.m. Pacific time). John Higgins, CEO will attend for Ligand.

A live webcast of the presentations will be available on Ligand’s website at www.ligand.com. A replay of the presentations will be archived on the website for 30 days.